Clinical Trials Directory

Trials / Unknown

UnknownNCT05567419

SARS-CoV-2 in Stools Compared to Respiratory Viral Strains.

SARS-CoV-2 in Stools Compared to Respiratory Viral Strains, in Patients Hospitalized for COVID-19.

Status
Unknown
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Central Hospital, Nancy, France · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to characterize and to quantify SARS-CoV-2 strains in stools, in comparison with the viral strains in respiratory samples, from patients hospitalized for COVID-19. The methods will be standard ddPCR quantifying SARS-CoV-2 RNA and next generation sequencing-whole genome sequencing. The expected results will allow us to better understand SARS-CoV-2 dynamics and compartmentalization, both in the respiratory tract and in digestive-related tissues, according to the evolution of SARS-CoV-2 variants.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBiological assaysPCR and NGS-WGS on stools and respiratory samples

Timeline

Start date
2022-11-01
Primary completion
2023-05-01
Completion
2025-05-01
First posted
2022-10-05
Last updated
2022-10-05

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05567419. Inclusion in this directory is not an endorsement.